Brought to you by 
Argentum buys TheraBond line from Alliqua for $3.8mm
03 Feb 2023
Executive Summary
Argentum Medical LLC paid $3.8mm to buy the TheraBond antimicrobial wound dressing line from Alliqua BioMedical Inc., which will use about half of the proceeds to repay existing debt.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Argentum buys TheraBond line from Alliqua for $3.8mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice